Clean Energy Technologies Declares Past Financial Statements Unreliable, Plans Restatements
summarizeSummary
Clean Energy Technologies, Inc. announced that its financial statements for nearly four years, from January 2022 to September 2025, are unreliable due to accounting errors, necessitating restatements.
check_boxKey Events
-
Non-Reliance on Financial Statements
The Board of Directors concluded that previously issued financial statements from January 1, 2022, to September 30, 2025, should no longer be relied upon.
-
Accounting Errors Identified
Issues relate to the historical classification, valuation, and collectability assessment of certain long-term receivables and contract assets, as well as the timing of revenue recognition and related interest income.
-
Extensive Restatements Planned
The Company intends to file amended Annual Reports on Form 10-K/A for 2023 and 2024, and amended Quarterly Reports on Form 10-Q/A for Q1, Q2, and Q3 2025.
-
Management and Auditor Discussion
The CEO, CFO, and Audit Committee Chair have discussed these matters with the independent registered public accounting firm, TAAD, LLP.
auto_awesomeAnalysis
Clean Energy Technologies, Inc. has disclosed that its financial statements from January 1, 2022, through September 30, 2025, should no longer be relied upon due to incorrect accounting practices. This critical disclosure, involving issues with long-term receivables, contract assets, and revenue recognition, significantly impacts investor confidence and raises concerns about the company's financial reporting integrity. While management states it does not affect current operations, the need for extensive restatements for multiple fiscal periods indicates material weaknesses in financial controls. Investors should anticipate potential delays in future filings and increased scrutiny, as the company works to rectify these issues and file amended reports.
At the time of this filing, CETY was trading at $0.83 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $12.3M. The 52-week trading range was $0.46 to $7.80. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.